Biosavety: Automatically decontaminating buildings, while you are present.

Germany
Niederwinkling, Bavaria, Germany, 14641

Company profile

Biosavety: Automatically decontaminating buildings, while you are present. company profile

Biosavety combines scientific excellence with social responsibility to develop advanced disinfection technologies that promote clean and healthy environments. Our mission focuses on protecting public health through innovative air purification without compromising the environment. Innovative Technology We have developed the first safe and effective air disinfection system, a significant advancement over existing air purification systems. In collaboration with Dräger, we created a sensor that operates with precision, allowing us to actively combat pathogens in the air and on surfaces, all while being safe for all living beings and materials. Focus on Sustainability Minimal amounts of water, salt, and electricity are sufficient to disinfect an entire building. Our approach eliminates unnecessary transportation and packaging through on-site production of the disinfectant, thereby reducing our ecological footprint. The service model we offer to our customers guarantees seamless maintenance and transparent monitoring. Social Responsibility As a team, we believe in the transformative power of science to provide sustainable and accessible solutions for global health promotion. We are committed to a cleaner, healthier, and more sustainable future for all, where pathogens do not dictate our daily lives.

Business identity

Contact email
[email protected]
Phone number
+491606460030
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0+
Founded
2020-05-01

Headquarters

Postal code
14641
Country code
DE
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
2
Total equity funding
$3.8M
Last funding
Series A / $3.8M / 2024-08-01
Last equity funding
Series A / $3.8M
Founders
2
Articles
8

Founders and investors

Founders

Dr. Thomas Bone-WinkelGreta Bone-Winkel